Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricHLNHaleon PLCZTSZoetisTEVATeva Pharmaceutical Industries Ltd
Snapshot
Price$8.80$69.84$39.55
Market cap$40.75B$33.26B$32.95B
Valuation
P/E19x11.2x25.8x
Forward P/E16.2x10.3x—
Growth
Revenue growth-1.8%2.4%4.4%
EPS growth17.6%8.4%—
Profitability
Net margin15.1%27.8%9.0%
ROE10.3%62.4%20.7%
Balance sheet & cash
Debt / equity0.52x2.72x2.12x
Free cash flow yield0.5%7.5%-10.5%
Dividend yield1.9%1.6%—
Verdict
Investment ratingNeutral· 48Favorable· 63Weak· 33

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearHLNtoday $9ZTStoday $70TEVAtoday $40
2027$7.76 – $11.38+29% CAGR$56.77 – $83.27+19% CAGR$30.97 – $45.42+15% CAGR
2028$9.12 – $13.38+23% CAGR$61.54 – $90.26+14% CAGR$32.34 – $47.43+10% CAGR
2029$10.73 – $15.73+21% CAGR$66.70 – $97.83+12% CAGR$33.76 – $49.52+8% CAGR
2030$12.61 – $18.50+20% CAGR$72.30 – $106.04+11% CAGR$35.25 – $51.70+7% CAGR
2031$14.83 – $21.74+20% CAGR$78.36 – $114.93+10% CAGR$36.81 – $53.98+6% CAGR
5-yr CAGR11.0% – 19.8%2.3% – 10.5%-1.4% – 6.4%